New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 12, 2014
09:24 EDTTGTXTG Therapeutics poised to advance next week, says Roth Capital
Roth Capital expects TG Therapeutics' A. Phase II combination data from the TG-1101 / Imbruvica study in B-cell malignancies. expected to be presented this weekend, to be strong. The firm expects the stock to rise at the beginning of next week, and it reiterates a Buy rating on the shares. The firm continues to identify the stock as a Focus Pick.
News For TGTX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 17, 2014
16:22 EDTTGTXRA Capital reports 8.3% passive stake in TG Therapeutics
October 9, 2014
12:04 EDTTGTXTG Therapeutics management to meet with Roth Capital
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use